13 October 2020

• ACTIV-3, a US-government-sponsored trial of Eli Lily’s monoclonal antibody, LY-CoV555, in people hospitalized with COVID-19, is paused, following a potential safety concern: one of the two groups (antibody recipients versus placebo recipients) was doing better than the other, The independent safety board plans a second review of the data on October 26. Sources 1,2,3
• As cases rise in Europe, the Netherlands announces a four-week partial lockdown, the Czech Republic announces closures of schools, theatres, zoos, bars, restaurants and cinemas; Slovakia has closed its schools, while Italy has prohibited parties and limited indoor gatherings to six people. Source

Return to the timeline